Host Cells Release Exosomes to Sop Up Bacterial Toxins

During bacterial infection, autophagy proteins appear to regulate the release of cell-saving exosomes, which bear the brunt of toxin damage.

Written byRachael Moeller Gorman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, Rost-9D

The paper
M.D. Keller et al., “Decoy exosomes provide protection against bacterial toxins,” Nature, 579:260–64, 2020.

To kill a cell, methicillin-resistant Staphylococcus aureus discharges an arsenal of toxins. Alpha-toxin is one of its favorites, forming a cylinder of sharp peptides that punches a hole in the host cell, popping it. MRSA is extremely virulent and resistant to many antibiotics, leading scientists to search for ways to defeat it.

Bacteriologist Victor Torres and cell biologist Ken Cadwell, both of New York University Grossman School of Medicine, had found in previous work that a key protein involved in autophagy also makes mice less susceptible to MRSA and alpha-toxin. But what was the connection between autophagy and MRSA infection? To find out, Torres, Cadwell, and graduate student Matthew Keller depleted the autophagy protein ATG16L1 in a human cell line and found that the cells then displayed unusually high numbers of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After earning a bachelor’s degree in biology and neuroscience from Williams College, Rachael spent two years studying the tiny C. elegans worm as a lab tech at Massachusetts General Hospital/Harvard University. She then returned to school to get a master’s degree in environmental studies from Brown University, and subsequently worked as an intern at Scientific AmericanDiscover magazine, and the Annals of Improbable Research, the originators of the yearly Ig Nobel prizes. She now freelances for both scientific and lay publications, and loves telling the stories behind the science. Find her at rachaelgorman.com or on Instagram @rachaelmoellergorman.

    View Full Profile

Published In

June 2020

An Infant's Bounty

Babies amass microbes that can pave the way to a healthy life

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies